image
TransCode Therapeutics, Inc. RNAZ
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 7.69
13.3 %
$ 6.41 M
Market Cap
-0.01
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
42.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets TransCode Therapeutics, Inc.
image
RNAZ has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart RNAZ

image
$30.0m$30.0m$25.0m$25.0m$20.0m$20.0m$15.0m$15.0m$10.0m$10.0m$5.0m$5.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RNAZ

image
$0.0$0.0($2.0m)($2.0m)($4.0m)($4.0m)($6.0m)($6.0m)($8.0m)($8.0m)($10.0m)($10.0m)($12.0m)($12.0m)($14.0m)($14.0m)($16.0m)($16.0m)($18.0m)($18.0m)($20.0m)($20.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RNAZ

image
$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)($1.6b)($1.6b)20232023202420242025202520262026202720272028202820292029